Lilly kicks off application for Alzheimer's drug U.S. approval, ups outlook

Eli Lilly on Tuesday raised its
2021 profit forecast, citing the strength in its core business
and higher sales of its COVID-19 antibody therapies, and said it
started the application process for the... | October 26, 2021

Related Keywords

United States ,Bengaluru ,Karnataka ,India ,Manojna Maddipatla ,Louise Chen ,Ankur Banerjee ,Tomasz Janowski ,Mrinalika Roy ,Cantor Fitzgerald ,Reuters ,Bengaluru Editing ,Biogen Inc Stock Exchange ,News ,Information ,Press Release ,Mali ,Illy ,N ,Tuesday ,Aised ,Profit ,Writing ,The ,Strength ,Its ,More ,Higher ,Sales ,F ,Ntibody ,End ,Aid ,Application ,Process ,Or Biib Us09062x1037 ,